Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Nov 21, 2016
Insider Transaction Report
Form 4
Wirth Edward
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2016-11-17$2.34/sh+2,500$5,850→ 2,500 total - Sale
Common Stock
2016-11-17$5.00/sh−2,500$12,500→ 0 total - Exercise/Conversion
Options to Purchase Common Stock
2016-11-17+2,500→ 197,500 totalExercise: $2.34From: 2013-03-10Exp: 2020-03-09→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]The shares reported herein were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person.
- [F2]Excludes 5,471 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report.